We observed a similar dichotomy in HER2-positive breast cancers, where a favourable WWOX/HIF1A ratio facilitates robust DNA repair and counteracts hypoxia-induced signalling, which would otherwise promote angiogenesis and glycolytic reprogramming linked to poor prognosis. Here, ERBB2 is linked to breast cancer.